바이오테크 보도자료
-
- Karen L. Ling joins Galderma’s Advisory Committee
- Galderma, the world’s largest independent dermatology company, announced today that Karen L. Ling will join its Advisory Committee, effective March 1, 2022. Karen Ling has a tremendous track record in executive roles at AIG, Allergan, Merck and Wy...
- 2022년 02월 18일
-
- NEC OncoImmunity Publishes a Unique HLA Typing Technology That Discovers New HLA Alleles, and Tumor Specific HLA Alleles
- NEC OncoImmunity AS (NOI) today announced a publication that describes a novel approach to type new HLA alleles and characterize the HLA of tumors to guide personalized cancer immunotherapy. The computational approach performs HLA typing from next...
- 2022년 02월 18일
-
- Vifor Pharma reports sustained growth in 2021
- Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma Group reported a solid performance in 2021 and an increase in profitability, supported by a strong recovery in Ferinject® / Injectafer® sales from the second quarter 2021 on,...
- 2022년 02월 17일
-
- Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
- Organon (NYSE: OGN) today announced that it has acquired the rights from Bayer AG to Marvelon® and Mercilon®, combined oral hormonal daily contraceptive pills, in the People’s Republic of China, including Hong Kong and Macau, and has entered into ...
- 2022년 02월 17일
-
- Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials
- Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials. Medidata will open access to it...
- 2022년 02월 16일
-
- German Federal Court of Justice Upholds AOP‘s License Rights in Ropeginterferon and PEC’s Liability for Damages.
- Since 2017, PharmaEssentia had repeatedly attempted to terminate the agreement with AOP concerning BESREMi® (Ropeginterferon alfa-2b). In October 2020, after two and a half years of arbitral proceedings, the ICC Arbitral Tribunal issued its award ...
- 2022년 02월 16일
-
- Vision Care Market is projected to account for over USD 127.73 Bn, in terms of value, by 2028 end: Future Market Insights
- The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems has increased and so is the need for vision care products and services. A...
- 2022년 02월 11일
-
- Theramex Reinforces its Commitment to Women on International Women’s Day
- International Women’s Day is an important date on the calendar to recognise and celebrate the social, economic, culture, political, scientific and many more achievements of women globally. At Theramex, every day is considered International Women’s...
- 2022년 02월 09일
-
- Modified Starch Market is expected to grow at a CAGR of ~5.6% during the forecast period 2022-2032: Future Market Insights
- According to a new market intelligence study published by Future Market Insights (FMI), modified starch market revenues are likely to reach ~US$ 12.6 Bn by 2022 end. Compared to developed regions, the sales value of modified starch is expected to ...
- 2022년 02월 09일
-
- Industrial Agitators Market to attain a net worth of USD 3.24 Billion by the end of 2027: Future Market Insights
- The global demand for industrial agitators is predicted to grow at a fairly robust rate, given its application versatility across several end-use industries. Apart from offering chemical stirring and liquid processing-as the traditional applicatio...
- 2022년 02월 09일
전시회
